European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci

被引:54
作者
Brazier, J. [1 ]
Chmelar, D. [1 ]
Dubreuil, L. [1 ]
Feierl, G. [1 ]
Hedberg, M. [1 ]
Kalenic, S. [1 ]
Kononen, E. [1 ]
Lundgren, B. [1 ]
Malamou-Ladas, H. [1 ]
Nagy, E. [1 ]
Sullivan, A. [1 ]
Nord, C. E. [1 ]
机构
[1] Karolinska Univ Hosp, Div Clin Microbiol, SE-14186 Stockholm, Sweden
关键词
antimicrobial resistance; clinical isolates; anaerobic cocci;
D O I
10.1016/j.ijantimicag.2007.11.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Gram-positive anaerobic cocci (GPAC) are a heterogeneous group of microorganisms frequently isolated from local and systemic infections. In this study, the antimicrobial susceptibilities of clinical strains isolated in 10 European countries were investigated. After identification of 299 GPAC to species level, the minimum inhibitory concentrations of penicillin, imipenem, clindamycin, metronidazole, vancomycin and linezolid were determined by the agar dilution method according to the Clinical and Laboratory Standards Institute. The majority of isolates were identified as Finegoldia magna and Parvimonas micra (formerly Peptostreptococcus micros), isolated from skin and soft tissue infections. All isolates were susceptible to imipenem, metronidazole, vancomycin and linezolid. Twenty-one isolates (7%) were resistant to penicillin (n = 13) and/or to clindamycin (n = 12). Four isolates were resistant to both agents. The majority of resistant isolates were identified as F. magna and originated from blood, abscesses and soft tissue infections. (C) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:316 / 320
页数:5
相关论文
共 22 条
[1]   Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].
Aldridge, KE ;
Ashcraft, D ;
Cambre, K ;
Pierson, CL ;
Jenkins, SG ;
Rosenblatt, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243
[2]   Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales [J].
Brazier, JS ;
Hall, V ;
Morris, TE ;
Gal, M ;
Duerden, BI .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (02) :224-228
[3]  
*CLIN LAB STAN I, 2007, M11A7C CLSI
[4]   Peptostreptococcus stomatis sp nov., isolated from the human oral cavity [J].
Downes, J ;
Wade, WG .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2006, 56 :751-754
[5]   Proposal of the genera Anaerococcus gen. nov., Peptoniphilus gen. nov and Gallicola gen. nov for members of the genus Peptostreptococcus [J].
Ezaki, T ;
Kawamura, Y ;
Li, N ;
Li, ZY ;
Zhao, LC ;
Shu, SE .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2001, 51 :1521-1528
[6]   Anaerobes: Antibiotic resistance, clinical significance, and the role of susceptibility testing [J].
Hecht, David W. .
ANAEROBE, 2006, 12 (03) :115-121
[7]   Prevalence of antibiotic resistance in anaerobic bacteria: Worrisome developments [J].
Hecht, DW .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :92-97
[8]  
Jousimies-Somer HR, 2002, WADSWORTH ANAEROBIC
[9]   Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents [J].
Koeth, LM ;
Good, CE ;
Appelbaum, PC ;
Goldstein, EJC ;
Rodloff, AC ;
Claros, M ;
Dubreuil, LJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) :1039-1044
[10]   Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources [J].
Kononen, Eija ;
Bryk, Anne ;
Niemi, Paivi ;
Kanervo-Nordstrom, Arja .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2205-2207